MENU
UPB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Upstream Bio (UPB) Ownership - Who owns Upstream Bio?
Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders... Show more
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
903.52M
P/E Ratio
N/A
Total Cash
393.58M
Projected Growth
N/A
Total Debt
1.56M
Revenue
2.72M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
7.30
Total Debt/Equity
N/A
Revenue/Share
0.05 USD as % of share price
Fundamentals
UPB
Capitalization
904M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
394M
Total Cash/Share
7.30
Total Debt
1.56M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.05%
Revenue
2.72M
ROE
N/A
Book Value
409M
P/B Ratio
2.21
Cash Flow
N/A
Earnings
-6.18
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
54K
Current Ratio
38.27
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-121.42M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-33.10
Shares Held By Institutions
483M
Shares Outstanding - Current
53.9M
Total Liabilities
11.8M
Total Volume MTD
N/A
Value
N/A
Gain YTD
1.946
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information